The mechanism of excretion of trientine from the rat kidney: trientine is not recognized by the H+/organic cation transporter.
Trientine dihydrochloride is used to treat Wilson's disease by chelating copper and increasing its urinary excretion. The mechanism of renal excretion of trientine has been investigated in-vivo and in-vitro. Trientine clearance in the rat-was significantly faster than creatinine clearance. When trientine and the same number of moles of copper ions were administered simultaneously to the rat, however, trientine clearance decreased to almost the same level as the creatinine clearance. To clarify this active excretion system for trientine, the uptake of trientine and a physiological polyamine compound, spermine, was investigated using rat renal brush-border membrane vesicles. Although, because trientine and spermine are organic cations, the H+/organic cation transporter is expected to recognize these compounds, neither an outwardly directed H+ gradient nor an inward Na+ gradient stimulated trientine uptake. [14C]Spermine uptake was, nevertheless, trans-stimulated by both unlabelled spermine and trientine and the trans-stimulating effect of spermine on trientine uptake was, furthermore, completely abolished by addition of copper ions to the incubation medium. These results suggest that there is a specific transport system for spermine and trientine on the renal brushborder membrane. This transport system contributes to the secretion of trientine in the kidney proximal tubule but does not recognize the trientine-copper complex.
Kobayashi
M
M
Department of Pharmacy, Hokkaido University Hospital, School of Medicine, Hokkaido University, Sapporo, Japan.
Tanabe
R
R
Sugawara
M
M
Iseki
K
K
Miyazaki
K
K
D000818:Animals; D001693:Biological Transport, Active; D002614:Chelating Agents / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D003124:Colorimetry; D003300:Copper / Q000008:administration & dosage / Q000652:urine*; D003404:Creatinine / Q000097:blood / Q000652:urine; D017136:Ion Transport / Q000187:drug effects; D007668:Kidney / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008871:Microvilli / Q000187:drug effects / Q000378:metabolism; D006180:Proton-Translocating ATPases / Q000378:metabolism; D011522:Protons; D051381:Rats; D017208:Rats, Wistar; D013050:Spectrometry, Fluorescence; D013096:Spermine / Q000008:administration & dosage / Q000652:urine; D014266:Trientine / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000652:urine*
D002614:Chelating Agents; D011522:Protons; D013096:Spermine; D003300:Copper; D003404:Creatinine; D006180:Proton-Translocating ATPases; D014266:Trientine